Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone
Brain and Behavior · 2023-08 · 13 (8)
DOI: 10.1002/brb3.3171 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Brain and Behavior, online erschienen am 21.07.2023. Verfasst von David M Kern und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Janssen Research & Development, Titusville, New Jersey, United States. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Research and Development.
Abstract (Originalsprache)
Background
The impact of treatment‐resistant depression (TRD) or prior suicidal ideation/suicide attempt (SI/SA) on mortality by suicide among patients with major depressive disorder (MDD) is not well known. This retrospective, observational, descriptive cohort study characterized real‐world rates of suicide‐specific mortality among patients with MDD with or without TRD or SI/SA.
Methods
Adult patients with MDD among commercially insured and Medicare enrollees in Optum Research Database were included and assigned to three cohorts: those with treatment‐resistant MDD (TRD), those with MDD and SI/SA (MDD+SI/SA), and those with MDD without TRD or SI/SA (MDD alone). Suicide‐specific mortality was obtained from the National Death Index. The effects of demographic characteristics and SI/SA in the year prior to the end of observation on suicide‐specific mortality were assessed.
Results
For the 139,753 TRD, 85,602 MDD+SI/SA, and 572,098 MDD alone cohort patients, mean age ranged from 55 to 59 years and the majority were female. At baseline, anxiety disorders were present in 53.92%, 44.11%, and 21.72% of patients with TRD, MDD+SI/SA, and MDD alone, respectively. Suicide‐mortality rates in the three cohorts were 0.14/100 person‐years for TRD, 0.27/100 person‐years for MDD+SI/SA, and 0.04/100 person‐years for MDD alone. SI/SA during the year prior to the end of observation, younger age, and male sex were associated with increased suicide risk.
Conclusions
Patients with TRD and MDD+SI/SA have a heightened risk of mortality by suicide compared with patients with MDD alone. Suicide rates were higher in patients with recent history versus older or no history of SI/SA, men versus women, and those of young age versus older age.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Janssen Research & Development, Titusville, New Jersey, United States.
- Optum, Eden Prairie, Minnesota.
ORCID-Profile: David M Kern
Förderung
- Janssen Research and Development
Zitieren
APA
Kern, D. M., Canuso, C. M., Daly, E., Johnson, J. C., Fu, D. J., Doherty, T., Blauer-Peterson, C., & Cepeda, M. S. (2023). Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone. Brain and Behavior, 13(8). https://doi.org/10.1002/brb3.3171
Vancouver
Kern DM, Canuso CM, Daly E, Johnson JC, Fu DJ, Doherty T, et al. Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone. Brain and Behavior. 2023;13(8). doi:10.1002/brb3.3171
BibTeX
@article{Kern2023,
author = {Kern, David M and Canuso, Carla M and Daly, Ella and Johnson, Jonathan C and Fu, Dong Jing and Doherty, Teodora and Blauer-Peterson, Cori and Cepeda, M Soledad},
title = {Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone},
journal = {Brain and Behavior},
year = {2023},
volume = {13},
number = {8},
doi = {10.1002/brb3.3171}
}
EUVIMED